Brolucizumab

CONDOR Trial Deep-Dive: Is Brolucizumab the New Paradigm for Treatment-Naïve PDR?

1. The PDR Management Shift: Beyond Laser Monotherapy For nearly half a century, Panretinal Photocoagulation (PRP) has been the cornerstone of Proliferative Diabetic Retinopathy (PDR) management. While the efficacy of…

2026-08-03

journal club

Intravitreal Anti VEGFs Current approach and future Prospective

https://aparat.com/v/XtC8U

2020-10-01

journal club

Faricimab

2019-09-29

Brolucizumab

Brolucizumab (also known as RTH258) is a humanized single-chain antibody fragment that inhibits all isoforms of VEGF-A with a molecular weight of 26 kDa. “On a molar basis, 6 mg…

2019-08-17